Ilan Zipkin

Director/Board Member at

Via Nova Therapeutics, Inc.

Health Technology

Finance

Consumer Services

Profile

Ilan Zipkin currently works at Via Nova Therapeutics, Inc., as Director.
Dr. Zipkin also formerly worked at Versanis Bio, Inc., as Co-Chief Executive Officer, Anteris Bio, Inc., as President & Chief Executive Officer, Tempero Bio, Inc., as Chief Executive Officer, Satori Pharmaceuticals, Inc., as Director, Chimeros, Inc., as Director, Alvine Pharmaceuticals, Inc., as Director, Bioniz Therapeutics, Inc., as Director, Takeda Ventures, Inc., as Senior Investment Director from 2000 to 2017, Quince Therapeutics, Inc., as Director, MPM BioImpact LLC, as Principal, and Prospect Venture Partners, as Partner.
Dr. Zipkin received his undergraduate degree from the University of California, Berkeley and doctorate degree from The University of California, San Francisco.

Ilan Zipkin active positions

Companies	Position	Start
Via Nova Therapeutics, Inc. Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections	Director/Board Member	-

All active positions of Ilan Zipkin

Former positions of Ilan Zipkin

Companies	Position	End
Takeda Ventures, Inc. Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements.	Private Equity Investor	01/06/2017
Chimeros, Inc. Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment	Director/Board Member	09/01/2014
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Private Equity Investor	01/06/2005
Anteris Bio, Inc. Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease	Chief Executive Officer	-
Tempero Bio, Inc. Tempero Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for substance use disorders and related conditions	Chief Executive Officer	-

See the detail of Ilan Zipkin's experience

Training of Ilan Zipkin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ilan Zipkin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Satori Pharmaceuticals, Inc. Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease	Health Technology
Chimeros, Inc. Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment	Health Technology
Alvine Pharmaceuticals, Inc. Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases	Health Technology
Bioniz Therapeutics, Inc. Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company	Commercial Services
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Prospect Venture Partners Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements.	Finance
Takeda Ventures, Inc. Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements.	Finance
Quince Therapeutics, Inc. Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases	Health Technology
Tempero Bio, Inc. Tempero Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for substance use disorders and related conditions	Health Technology
Versanis Bio, Inc. Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology
Via Nova Therapeutics, Inc. Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections	Health Technology
Anteris Bio, Inc. Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease	Health Technology